Clinical Pharmacology Study of MP-424 in Healthy Male Adult Volunteers (Single- and Multiple-Dose Study)
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2013
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jan 2013 New trial record